MAVISp: A Modular Structure-Based Framework for Protein Variant Effects
Matteo Arnaudi,Ludovica Beltrame,Kristine Degn,Mattia Utichi,Simone Scrima,Pablo Sanchez-Izquierdo Besora,Karolina Krzesinska,Francesca Maselli,Terezia Dorcakova,Jordan Safer,Alberte Heering Estad,Katrine Meldgard,Philipp Becker,Valentina Sora,Alberto Pettenella,Jeremy Vinhas,Laura Bauer,Paraskevi Saridaki,Anna Melidi,Lorenzo Favaro,Eleni Kiachaki,Anu Oswal,Joachim Breitenstein,Burcu Aykac Fas,Guglielmo Tedeschi,Peter Wad Sackett,Claudia Cava,Anna Rohlin,Mef Nilbert,Sumaiya Iqbal,Matteo Lambrughi,Matteo Tiberti,Elena Papaleo
DOI: https://doi.org/10.1101/2022.10.22.513328
2024-11-08
Abstract:The role of genomic variants in disease has expanded significantly with the advent of advanced sequenc-ing techniques. The rapid increase in identified genomic variants has led to many variants being classi-fied as Variants of Uncertain Significance or as having conflicting evidence, posing challenges for their interpretation and characterization. Additionally, current methods for predicting pathogenic variants often lack insights into the underlying molecular mechanisms. Here, we introduce MAVISp (Multi-layered As-sessment of VarIants by Structure for proteins), a modular structural framework for variant effects, ac-companied by a web server (https://services.healthtech.dtu.dk/services/MAVISp-1.0/) to enhance data accessibility, consultation, and re-usability. MAVISp currently provides data for 500 proteins, encompass-ing over four million variants. A team of biocurators regularly analyze and update protein entries using standardized workflows, incorporating free energy calculations or biomolecular simulations. We illustrate the utility of MAVISp through selected case studies. The framework facilitates the analysis of variant ef-fects at the protein level and has the potential to advance the understanding and application of mutational data in disease research.
Bioinformatics